風邪薬の世界市場レポート 2025年

風邪薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.2%で、126億4,000万米ドルに成長します。予測期間に予測される成長は、研究開発投資の増加、予防ヘルスケアに対する意識の高まり、ホリスティックヘルスアプローチの増加、消費者の健康意識の高まり、政府の支援政策などに起因すると考えられます。この期間に予想される主な動向には、革新的なソリューションの出現、技術の進歩、新規製品の処方、個別化医療、オーダーメイドの免疫強化ソリューションへのシフトなどがあります。

呼吸器感染症の罹患率の増加が、今後数年間の風邪薬市場の成長を牽引すると予想されます。呼吸器感染症は、副鼻腔、咽頭、気道、肺などの呼吸器系に影響を及ぼす疾患で、ウイルス、細菌、その他の病原体によって引き起こされます。このような感染症の急増は、パンデミックに関連した長期間の閉鎖に伴う免疫力の低下や、社会的距離の縮小による一般的なウイルスへの曝露の減少が主な原因となっています。風邪薬は、鼻づまり、咳、のどの痛みなどの症状を和らげ、体が回復するまでの間、症状を緩和する重要な役割を果たします。例えば、2023年3月、英国の政府機関である国家統計局は、イングランドでCOVID-19感染が増加し、人口の約2.66％（40人に1人に相当）が陽性と判定され、入院患者数は人口10万人当たり10.62人に増加したと報告しました。したがって、呼吸器感染症の有病率の上昇が風邪薬市場の拡大に寄与しています。

風邪薬市場の主なプレーヤーは、より安全で自然な代替品を求める消費者需要の高まりに対応するため、革新的なクリーンラベル製品の開発に注力しています。クリーンな咳止め薬や風邪薬は、人工色素、甘味料、防腐剤、一般的なアレルゲンを使用せず、代わりに天然成分やオーガニック成分を利用して効果的な症状緩和をもたらすよう処方されています。例えば、2023年9月、米国のヘルスケア企業Genexa Inc.は、Kids'Multi-Symptom Cold And FluやKids'Daytime+Nighttime Cough Relief Value Packなど、クリーンラベルの新しい子供用咳・風邪薬を発売しました。これらの製剤は、人工色素、パラベン、甘味料、アレルゲンを排除し、天然ベースとして有機アガベシロップを配合しています。従来の薬の効果を維持しながら、無害でクリーンな代替品を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の風邪薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の風邪薬市場：成長率分析
• 世界の風邪薬市場の実績：規模と成長, 2019-2024
• 世界の風邪薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の風邪薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の風邪薬市場：薬剤タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗ヒスタミン薬
• 去痰薬
• 気管支拡張薬
• 鼻づまり解消薬
• 抗生物質
• その他の薬剤
• 世界の風邪薬市場：投与タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口シロップ
• 錠剤と丸薬
• 点鼻薬
• トローチ
• その他の投与タイプ
• 世界の風邪薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• ドラッグストア
• スーパーマーケットとハイパーマーケット
• eコマースとオンライン薬局
• 世界の風邪薬市場、抗ヒスタミン薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 第一世代抗ヒスタミン薬
• 第二世代抗ヒスタミン薬
• 複合抗ヒスタミン薬
• 世界の風邪薬市場、去痰薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• グアイフェネシン系去痰薬
• ハーブ去痰薬
• 複合去痰薬
• 世界の風邪薬市場、気管支拡張薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ベータ作動薬
• 抗コリン薬
• メチルキサンチン
• 世界の風邪薬市場、充血除去薬、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口充血除去薬
• 鼻づまり解消スプレー
• 複合充血除去薬
• 世界の風邪薬市場、抗生物質、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• ペニシリン系抗生物質
• マクロライド
• セファロスポリン
• 世界の風邪薬市場、その他の医薬品、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛剤
• 咳止め薬
• ハーブ療法とホメオパシー療法

第7章 地域別・国別分析

• 世界の風邪薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の風邪薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 風邪薬市場：競合情勢
• 風邪薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc
• Reckitt Benckiser Group plc
• Teva Pharmaceutical Industries Ltd.
• Haleon plc
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company plc
• Prestige Brands Holdings Inc.
• Weefsel Pharma Pvt. Ltd.
• Sunwin Healthcare Pvt. Ltd.
• AdvaCare Pharma USA
• Centurion Remedies Private Limited
• Himalaya Wellness Company
• Genexa Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 風邪薬市場2029：新たな機会を提供する国
• 風邪薬市場2029：新たな機会を提供するセグメント
• 風邪薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Cold remedies are treatments designed to relieve symptoms of the common cold, including congestion, cough, and sore throat. These remedies may include medications, natural therapies, and supportive care, aiming to enhance comfort and promote recovery, though they do not cure the viral infection itself.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary drug types used in cold remedies include antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. Antihistamines work by blocking histamine receptors to ease allergy-related symptoms such as sneezing, itching, and nasal congestion. Cold remedies come in various dosage forms, including oral syrups, tablets and pills, nasal drops, lozenges, and others. They are distributed through multiple channels such as hospital pharmacies, retail pharmacies, drug stores, supermarkets and hypermarkets, as well as e-commerce and online pharmacies.

The cold remedies market research report is one of a series of new reports from The Business Research Company that provides cold remedies market statistics, including the cold remedies industry global market size, regional shares, competitors with the cold remedies market share, detailed cold remedies market segments, market trends, and opportunities, and any further data you may need to thrive in the cold remedies industry. These cold remedies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cold remedies market size has grown strongly in recent years. It will grow from$9.31 billion in 2024 to $9.91 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be attributed to the increasing prevalence of respiratory infections, a growing geriatric population, rising demand for effective combination products, an increased shift from prescription (Rx) to over-the-counter (OTC) medications, and heightened consumer demand for fast and effective symptom relief.

The cold remedies market size is expected to see strong growth in the next few years. It will grow to$12.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth projected for the forecast period can be attributed to increased investment in research and development, growing awareness of preventive healthcare, a rise in holistic health approaches, increasing health consciousness among consumers, and supportive government policies. Key trends expected during this period include the emergence of innovative solutions, technological advancements, novel product formulations, personalized medicine, and a shift toward tailored, immune-boosting solutions.

The increasing incidence of respiratory infections is anticipated to drive the growth of the cold remedies market in the coming years. Respiratory infections are illnesses that impact the respiratory system-such as the sinuses, throat, airways, and lungs-and are caused by viruses, bacteria, or other pathogens. A surge in these infections is largely attributed to weakened immune systems following prolonged pandemic-related lockdowns and reduced exposure to common viruses due to social distancing. Cold remedies play a crucial role in easing symptoms such as congestion, cough, and sore throat, offering symptomatic relief while the body recovers. For example, in March 2023, the Office for National Statistics, a UK-based government agency, reported that COVID-19 infections rose in England, with approximately 2.66% of the population testing positive (equivalent to 1 in 40 individuals), and hospital admissions increased to 10.62 per 100,000 people. Hence, the rising prevalence of respiratory infections is contributing to the expansion of the cold remedies market.

Key players in the cold remedies market are focusing on the development of innovative clean-label products to cater to rising consumer demand for safer, more natural alternatives. Clean cough and cold medicines are formulated without artificial dyes, sweeteners, preservatives, or common allergens, instead utilizing natural or organic ingredients to deliver effective symptom relief. For instance, in September 2023, Genexa Inc., a US-based healthcare company, launched new clean-label cough and cold medicines for children, including the Kids' Multi-Symptom Cold And Flu and the Kids' Daytime + Nighttime Cough Relief Value Pack. These formulations exclude artificial dyes, parabens, sweeteners, and allergens, and incorporate organic agave syrup as a natural base. They maintain the effectiveness of conventional medications while offering a non-toxic, clean alternative.

In February 2024, Cipla Limited, an India-based pharmaceutical firm, acquired Actor Pharma for $48.6 million. This acquisition is part of Cipla's strategy to enhance its over-the-counter (OTC) product lineup, broaden its consumer healthcare offerings, and solidify its footprint in the self-care and wellness space. Actor Pharma (Pty) Limited, based in South Africa, is known for manufacturing expectorants and contributes valuable expertise and product capabilities to Cipla's growing OTC portfolio.

Major players in the cold remedies market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Haleon plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Prestige Brands Holdings Inc., Weefsel Pharma Pvt. Ltd., Sunwin Healthcare Pvt. Ltd., AdvaCare Pharma USA, Centurion Remedies Private Limited, Himalaya Wellness Company, Genexa Inc., and Fibovil Pharmaceuticals Pvt. Ltd.

North America was the largest region in the cold remedies market in 2024. The regions covered in cold remedies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cold remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold remedies market consists of sales of inhalers, topical rubs, throat sprays, homeopathic remedies, and vitamin supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cold Remedies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cold remedies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cold remedies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold remedies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Antihistamines; Expectorants; Bronchodilators; Decongestants; Antibiotics; Other Drugs
• 2) By Dosage Type: Oral Syrups; Tablets And Pills; Nasal Drops; Lozenges; Other Dosage Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Supermarkets And Hypermarkets; E-Commerce And Online Pharmacies
• Subsegments:
• 1) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines; Combination Antihistamines
• 2) By Expectorants: Guaifenesin-Based Expectorants; Herbal Expectorants; Combination Expectorants
• 3) By Bronchodilators: Beta-Agonists; Anticholinergics; Methylxanthines
• 4) By Decongestants: Oral Decongestants; Nasal Spray Decongestants; Combination Decongestants
• 5) By Antibiotics: Penicillin-Based Antibiotics; Macrolides; Cephalosporins
• 6) By Other Drugs: Pain Relievers; Cough Suppressants; Herbal And Homeopathic Remedies
• Companies Mentioned: Pfizer Inc.; The Procter & Gamble Company; Johnson & Johnson; Bayer AG; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cold Remedies Market Characteristics

3. Cold Remedies Market Trends And Strategies

4. Cold Remedies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cold Remedies Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cold Remedies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cold Remedies Market Growth Rate Analysis
• 5.4. Global Cold Remedies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cold Remedies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cold Remedies Total Addressable Market (TAM)

6. Cold Remedies Market Segmentation

• 6.1. Global Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihistamines
• Expectorants
• Bronchodilators
• Decongestants
• Antibiotics
• Other Drugs
• 6.2. Global Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Syrups
• Tablets And Pills
• Nasal Drops
• Lozenges
• Other Dosage Types
• 6.3. Global Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Supermarkets And Hypermarkets
• E-Commerce And Online Pharmacies
• 6.4. Global Cold Remedies Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• First-Generation Antihistamines
• Second-Generation Antihistamines
• Combination Antihistamines
• 6.5. Global Cold Remedies Market, Sub-Segmentation Of Expectorants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Guaifenesin-Based Expectorants
• Herbal Expectorants
• Combination Expectorants
• 6.6. Global Cold Remedies Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Beta-Agonists
• Anticholinergics
• Methylxanthines
• 6.7. Global Cold Remedies Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Decongestants
• Nasal Spray Decongestants
• Combination Decongestants
• 6.8. Global Cold Remedies Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillin-Based Antibiotics
• Macrolides
• Cephalosporins
• 6.9. Global Cold Remedies Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Relievers
• Cough Suppressants
• Herbal And Homeopathic Remedies

7. Cold Remedies Market Regional And Country Analysis

• 7.1. Global Cold Remedies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cold Remedies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cold Remedies Market

• 8.1. Asia-Pacific Cold Remedies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cold Remedies Market

• 9.1. China Cold Remedies Market Overview
• 9.2. China Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cold Remedies Market

• 10.1. India Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cold Remedies Market

• 11.1. Japan Cold Remedies Market Overview
• 11.2. Japan Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cold Remedies Market

• 12.1. Australia Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cold Remedies Market

• 13.1. Indonesia Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cold Remedies Market

• 14.1. South Korea Cold Remedies Market Overview
• 14.2. South Korea Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cold Remedies Market

• 15.1. Western Europe Cold Remedies Market Overview
• 15.2. Western Europe Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cold Remedies Market

• 16.1. UK Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cold Remedies Market

• 17.1. Germany Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cold Remedies Market

• 18.1. France Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cold Remedies Market

• 19.1. Italy Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cold Remedies Market

• 20.1. Spain Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cold Remedies Market

• 21.1. Eastern Europe Cold Remedies Market Overview
• 21.2. Eastern Europe Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cold Remedies Market

• 22.1. Russia Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cold Remedies Market

• 23.1. North America Cold Remedies Market Overview
• 23.2. North America Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cold Remedies Market

• 24.1. USA Cold Remedies Market Overview
• 24.2. USA Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cold Remedies Market

• 25.1. Canada Cold Remedies Market Overview
• 25.2. Canada Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cold Remedies Market

• 26.1. South America Cold Remedies Market Overview
• 26.2. South America Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cold Remedies Market

• 27.1. Brazil Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cold Remedies Market

• 28.1. Middle East Cold Remedies Market Overview
• 28.2. Middle East Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cold Remedies Market

• 29.1. Africa Cold Remedies Market Overview
• 29.2. Africa Cold Remedies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cold Remedies Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cold Remedies Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cold Remedies Market Competitive Landscape And Company Profiles

• 30.1. Cold Remedies Market Competitive Landscape
• 30.2. Cold Remedies Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Cold Remedies Market Other Major And Innovative Companies

• 31.1. AstraZeneca plc
• 31.2. Novartis AG
• 31.3. GlaxoSmithKline plc
• 31.4. Reckitt Benckiser Group plc
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Haleon plc
• 31.7. Sun Pharmaceutical Industries Ltd.
• 31.8. Perrigo Company plc
• 31.9. Prestige Brands Holdings Inc.
• 31.10. Weefsel Pharma Pvt. Ltd.
• 31.11. Sunwin Healthcare Pvt. Ltd.
• 31.12. AdvaCare Pharma USA
• 31.13. Centurion Remedies Private Limited
• 31.14. Himalaya Wellness Company
• 31.15. Genexa Inc.

32. Global Cold Remedies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cold Remedies Market

34. Recent Developments In The Cold Remedies Market

35. Cold Remedies Market High Potential Countries, Segments and Strategies

• 35.1 Cold Remedies Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cold Remedies Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cold Remedies Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34799_Cold_Remedies_GMR_2025